Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

NCT06066580 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Becker Muscular Dystrophy

Interventions

DRUG: Sevasemten

Sponsor

Edgewise Therapeutics, Inc.

Collaborators

[object Object]